Resource use and societal costs for Crohn's disease in Sweden

Inflammatory Bowel Diseases

Volumn 15, Issue 12, 2009, Pages 1882-1890

  Mesterton, Johan ^a   Jönsson, Linus ^a   Almer, Sven H C ^b   Befrits, Ragnar ^c   Friis Liby, Ingalill ^d   Lindgren, Stefan ^e  

^a i3 Innovus   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Costs; Crohn's disease; Harvey Bradshaw index; Quality of life

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; TUMOR NECROSIS FACTOR ANTIBODY;

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOMEOPATHY; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; RETROSPECTIVE STUDY; SWEDEN; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CROHN DISEASE; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SWEDEN; YOUNG ADULT;

EID: 72549089752     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20939     Document Type: Article

References (43)

1. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol. 2006;12:75-81.
2. Statistics Sweden. Population statistics: http://www.scb.se/templates/ tableOrChart-25896.asp (accessed 24 April 2008).
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517. (Pubitemid 38649869)
4. Feagan BG, Bala M, Yan S, et al. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol. 2005;39:390-395. (Pubitemid 40548076)
5. Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000;95:1955-1960.
6. Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004;53:1471-1478. (Pubitemid 39265268)
7. Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics. 2006;24:797-814. (Pubitemid 44232107)
8. Juan J, Estiarte R, Colome E, et al. Burden of illness of Crohn's disease in Spain. Dig Liver Dis. 2003;35:853-861. (Pubitemid 41070490)
9. Odes S, Vardi H, Friger M, et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology. 2006;131:719-728. (Pubitemid 44307060)
10. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
11. Reilly Associates. Work Productivity and Activity Impairment Questionnaire: Specific Health Problem. Reilly Associates (www.reillyassociates. net).
12. Reilly MC, Gerlier L, Brabant Y, et al. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin Ther. 2008;30:393-404.
13. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population- based cohort. Gastroenterology. 1999;117:49-57.
14. Regional price list. Södra regionvårdsnämnden: http://www.skane.se/templates/Page.aspx?id=190940 (accessed 18 September 2007).
15. Regional price list. Samverkansnämnden, Västra Götalandsregionen: http://www.vgregion.se/upload/svn%20- %20samverkansnämden/PDF-fil%20utomlänsprislista%202007.pdf (accessed 18 September 2007).
16. Regional price list. Stockholm-Gotland regionen: http://extern.bkv.sll. se/samv.sthlm-gotland/Prislistor/2007/karolinskaULP07-bil2.pdf (accessed 18 September 2007).
17. Regional price list. Sydöstra sjukvårdsregionen: http://www.lio.se/upload/16047/Prislista%202007.pdf (accessed 18 September 2007).
18. The Pharmaceutical Benefits Board. Price information of pharmaceuticals: The Pharmaceutical Benefits Board. http://www.lfn.se/LFNTemplates/ ProductDispSearch-564.aspx (accessed 25 September 2007).
19. Drummond M, O'Brien B, Stoddard G, et al. Methods for the economic evaluation of health care programmes, 3rd ed. Oxford: Oxford University Press; 2005.
20. Statistics Sweden. Average base salary and monthly salary 2004-2006 (Genomsnittlig grund-och månadslön samt kvinnors lön i procent av mäns lön efter sektor, yrkesgrupp (SSYK), kön och utbildningsnivå (SUN). År 2004-2006): www.scb.se (accessed 12 September 2007).
21. Ekonomifakta. Social benefits (Sociala avgifter): Confederation of Swedish enterprise. http://www.ekonomifakta.se/sv/Fakta/Arbetsmarknad/ Arbetsgivaravgift (accessed 12 September 2007).
22. Statistics Sweden. Consumer price index: http://www.scb.se/templates/ tableOrChart-33847.asp (accessed 12 September 2007).
23. Eurostat. Euro exchange rates, annual data: http://epp.eurostat.ec. europa.eu (accessed 23 April 2008).
24. Regional price list. Uppsala-Örebroregionen: http://www.externt9. lul.se/svn/priser07.htm (accessed 18 September 2007).
25. Statistics Sweden. The Salary Database (Lönedatabasen): http://www.scb.se/templates/Standard-36110.asp (accessed 12 September 2007).
26. Swedish Association of Psychologists, 2004 (pers. commun.).
27. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33:328-336. (Pubitemid 32675373)
28. Vermeire S, Schreiber S, Sandborn W, et al. Determination of Harvey-Bradshaw Index (HBI) definitions for response and remission using the CDAI data from PRECiSE 1 and PRECiSE 2. Gastroenterology. 2007;132:A-506.
29. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman & Hall; 1993.
30. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6:327-340.
31. Maritz JS. Distribution-free Statistical Methods. London: Chapman & Hall; 1995.
32. Dunn G, Mirandola M, Amaddeo F, et al. Describing, explaining or predicting mental health care costs: a guide to regression models. Methodological review. Br J Psychiatry. 2003;183:398-404. (Pubitemid 37357570)
33. Longobardi T, Jacobs P, Bernstein CN. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Am J Gastroenterol. 2004;99:650-655. (Pubitemid 38607968)
34. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol. 1997;32:1134-1139. (Pubitemid 27523846)
35. Yu AP, Cabanilla LA, Wu EQ, et al. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2008;24:319-328.
36. Eurostat. Harmonized Indices of Consumer Prices: http://epp.eurostat.ec. europa.eu (accessed 23 April 2008).
37. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992;14:309-317.
38. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:731-743. (Pubitemid 43825804)
39. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30:699-706.
40. Moock J, Kohlmann T. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res. 2008;17:485-495.
41. Buxton MJ, Lacey LA, Feagan BG, et al. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility. Value Health. 2007;10:214-220.
42. Gibson PR, Weston AR, Shann A, et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol. 2007;22:1306-1312. (Pubitemid 47222660)
43. Lanzieri G. Population in Europe 2007: first results: Eurostat, 2008.